Case report
12
/l (normal range 0.02-0.1 × 10 12 /l) following engraftment (see Figure 1 ). Bone marrow aspiration on day +24 showed the presence of megakaryocytes and granulopoiesis but complete Various immunohematologic complications may occur absence of erythroblasts consistent with PRCA. There was after BMT, especially in the setting of ABO incompatibility no evidence of hemolysis, blood loss or acute GVHD. CYA and/or in T cell-depleted grafts, 1,2 with reported incidences was tapered from day +50 and was discontinued on day of 21% 2 and 20%, 3 respectively. Pure red cell aplasia +180. The patient remained transfusion-dependent with (PRCA) following BMT has been described, 1 but surprisreticulocytopenia and initially with no detectable circulatingly only eight cases have been reported after T celling group A (recipient) red blood cells. Washed group O depleted BMT. 3, 4 Immunologic mechanisms are probably red blood cells were transfused during this period, and on involved in its pathogenesis, but its optimum management day +133 her blood group converted to type A with a conremains controversial due to the few cases reported. Some comitant slight increase in the absolute RET count to a patients have responded to immunosuppressive therapy 6-10 maximum of 0.06 × 10 12 /l. However, she remained transor plasma exchange.
4,5 Erythropoietin (EPO), on the other fusion-dependent, and blood group A transfusions were hand, has the advantage of having fewer secondary begun (two to four packed red blood cell concentrates per effects. [11] [12] [13] We report a case of PRCA following a major month). Bone marrow examinations performed over the fol-ABO-incompatible T cell-depleted BMT that was successlowing months showed normal myeloid and megakaryfully treated with EPO.
ocytic engraftment with a small percentage (2-10%) of erythroid precursors. Chimerism studies of both peripheral blood and bone marrow performed by PCR analysis of VNTR sequences showed persistent complete donor chimerism. On day +320 the RET count dropped to levels below 0.03 × 10
Hemoglobin (g/l) started at 150 U/kg (total dose 8250 U/day) three times per cases of PRCA complicating major ABO-incompatible BMT, 1-13 with 10 unmanipulated grafts and eight T cellweek. Within 10 days, a marked increase of the absolute RET count and Hb levels was observed, with an absolute depleted transplants. Only one case following ABOcompatible BMT has been described, 10 suggesting that RET count of 1.53 × 10 12 /l and a Hb concentration of 152 g/l. EPO therapy was tapered over 2 weeks and the Hb major ABO incompatibility is the key inciting event in its pathogenesis. High persistent titers of host anti-donor remains above 120 g/l at 19 months post-BMT (Figure 1) .
isohemagglutinins have been documented in most cases of PRCA or the related condition of delayed erythroid engraftment. [2] [3] [4] 8 In some cases, however, titers of isohemDiscussion agglutinins are low or undetectable, 6,7,11 suggesting that cell-mediated immune mechanisms may be implicated (see Numerous immunohematologic complications may develop after BMT. Their pathogenesis in allogeneic transplants Table 1 ). The persistence of host immunocompetent antibody-producing and/or T cell clones is probably responsible appears to derive from the coexistence of two separate immune and hematopoietic systems. 1, 4 We have found 18 for the alloimmune inhibition of erythropoiesis, 3,4 and the 
